[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. [electronic resource]
- Revista de neurologia Jan 2011
- 101-11 p. digital
Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review
1576-6578
AIDS Dementia Complex--drug therapy Animals Anti-HIV Agents--therapeutic use Apoptosis Biomarkers--metabolism Central Nervous System--pathology Clinical Trials as Topic Encephalitis--pathology HIV Envelope Protein gp120--metabolism HIV Infections--drug therapy HIV-1--pathogenicity Humans Nerve Degeneration--pathology Neurons--pathology Receptors, CXCR4--metabolism tat Gene Products, Human Immunodeficiency Virus--metabolism